Polkinghorne Kevan Roy, Seneviratne Mechelle, Kerr Peter G
Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia.
Am J Kidney Dis. 2009 Jan;53(1):99-106. doi: 10.1053/j.ajkd.2008.06.026. Epub 2008 Sep 21.
Starting hemodialysis therapy with an arteriovenous fistula (AVF) is associated with improved patient survival. Clinical audit showed that less than 50% of our patients started hemodialysis therapy with an AVF.
Quality improvement report, prospective before and after study.
SETTING & PARTICIPANTS: Tertiary referral hospital with 184 patients starting hemodialysis therapy in 2005 and 2006.
Situational analysis showed poor overall coordination of surgical waiting lists. Multifaceted intervention included vascular access nurse coordinator and an algorithm to prioritize surgery.
Vascular access used at first hemodialysis treatment in patients with pre-end-stage renal disease in the 12 months before and after the intervention.
Proportions of patients starting hemodialysis therapy with an AVF.
Overall, 65% of patients started hemodialysis therapy with an AVF; 2%, with an arteriovenous graft; and 33%, with a catheter. The proportion of patients starting hemodialysis therapy with an AVF increased from 56% preimplementation to 75% postimplementation (P = 0.007). After adjustment for age, sex, late referral, cause of renal failure, and presentation type, patients starting dialysis therapy in the implementation phase were twice as likely to start treatment with an AVF (odds ratio, 2.85; P = 0.008). The total number of catheter-days in the implementation phase was half that of the preimplementation phase (2,833 v 4,685 days).
Nonrandomized study.
Implementation of a multifaceted intervention including a vascular access nurse and an algorithm to prioritize surgery significantly increased the proportion of patients starting dialysis therapy with an AVF by improving the overall coordination of the surgical waiting list.
开始使用动静脉内瘘(AVF)进行血液透析治疗与患者生存率提高相关。临床审计显示,我们的患者中不到50%开始使用AVF进行血液透析治疗。
质量改进报告,前瞻性前后对照研究。
一家三级转诊医院,2005年和2006年有184名患者开始血液透析治疗。
情况分析显示手术等候名单的整体协调不佳。多方面干预措施包括血管通路护士协调员和一种确定手术优先级的算法。
干预前后12个月内终末期肾病前期患者首次血液透析治疗时使用的血管通路。
开始使用AVF进行血液透析治疗的患者比例。
总体而言,65%的患者开始使用AVF进行血液透析治疗;2%使用动静脉移植物;33%使用导管。开始使用AVF进行血液透析治疗的患者比例从实施前的56%增至实施后的75%(P = 0.007)。在对年龄、性别、延迟转诊、肾衰竭病因和就诊类型进行调整后,在实施阶段开始透析治疗的患者使用AVF开始治疗的可能性是原来的两倍(优势比,2.85;P = 0.008)。实施阶段的导管使用总天数是实施前阶段的一半(2833天对4685天)。
非随机研究。
实施包括血管通路护士和确定手术优先级算法在内的多方面干预措施,通过改善手术等候名单的整体协调,显著提高了开始使用AVF进行透析治疗的患者比例。